abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

這頁面沒有繁體中文版本,現以English顯示

文章

2010年5月27日

作者:
Global Business Coalition on HIV/AIDS, TB and Malaria (GBC)

Business Delivers as Front-Line Player in the Global Fight against HIV/AIDS, TB and Malaria

From an initiative that’s reaching 3.5 million people threatened by TB to a massive expansion of access to cheap anti-malaria medication in 24 African countries, businesses are doing work that is complementing the global health work of governments and international agencies…Eight companies will receive GBC's Awards for Excellence in Business Action…"Governments and non-profits can’t do it alone. The private sector needs to step up now…” said GBC President and CEO John Tedstrom...[awards given to Boehringer Ingelheim, Coca-Cola Africa Foundation, Eli Lilly, ExxonMobil, NBA, Newmont Ghana Gold, Sanofi-Aventis, Standard Chartered; GBC commended Accor, Bayer, Diageo, Heineken, Heineken International & Unilever Partnership, Lonmin, L’Oreal China, Standard Bank]